Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Efficacy of combination therapy with sitagliptin compared with the thiazolidinedione in patients with type 2 diabetes inadequately controlled on metformin and sulfonyureas

  • At: 2009 FIP Congress in Istanbul (Turkey)
  • Type: Poster
  • By: CHIA-CHEN, Huang (Department of Pharmacy, E-Da Hospital, Kaohsiung County, China Taiwan)
  • Co-author(s): Hsiu-Ling, Chang (Department of Pharmacy, E-Da Hospital, KAOHSIUNG COUNTY, China Taiwan)
    Mei-Fang, Lin (Department of Pharmacy, E-Da Hospital, KAOHSIUNG COUNTY, China Taiwan)
    Pin-Chin, Tsai (Department of Pharmacy, E-Da Hospital, KAOHSIUNG COUNTY, China Taiwan)
  • Abstract:

    Objective: To aim of this study was to assess the effect of sitagliptin, a high selective once-daily oral dipeptidy peptidase-4 (DPP-4) inhibitor, when added to ongoing metformin/sulfonyureas therapy in patients with type 2 diabetes who had inadequate glycemic controlled on metformin and sulfonyureas combination therapy.

    Methods:The research was..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses